AKT1 and hepatocellular carcinoma: Aberrant activation of the PI3K/AKT pathway is often found in different types of human cancer, including HCC, which might be explained by the hotspot PI3KCA mutations and AKT gene amplifications as well as the increase in phosphorylation of AKT (17).